Episode Details

Youths 12 and older have been eligible for COVID-19 vaccines since March, but clinical trials are still ongoing for kids under 12. Dr. Kawsar Talaat, who led one of Pfizer’s COVID-19 vaccine trials in adults, and Dr. Odis Johnson, executive director of the Johns Hopkins Center for Safe and Healthy Schools, return to the podcast to talk with Stephanie Desmon about whether schools may require vaccines, the ethics of immunizing children when so many high-risk adults around the world don’t have access to shots, risk factors for serious disease among children, and what is known currently about vaccine hesitancy among parents.